Valuation : Southern Acids (M)

Market Cap 430M 106M 91.39M 85.96M 78.47M 147M 10.05B 147M 1.02B 394M 5.15B 399M 390M 16.39B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value 3.51M 867K 745K 701K 640K 1.2M 81.98M 1.2M 8.31M 3.21M 41.98M 3.26M 3.18M 134M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
08-28 Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Member of Nomination and Remuneration Committee, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Retirement of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Non Independent and Non Executive Director, Effective August 28, 2026 CI
08-28 Southern Acids (M) Berhad Announces Appointment of Dato' Sri Dr Low Kok Thye as Acting Chairman, Effective August 28, 2026 CI
08-27 Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
08-13 Southern Acids (M) Berhad Reports Group Production Results for the Month of July 2026 CI
08-05 Southern Acids (M) Berhad Announces Redesignation of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie from Independent Director to Non-Independent Director, Effective August 5, 2026 CI
07-27 Southern Acids (M) Berhad Announces Single Tier Final Dividend on Ordinary Share for Financial Year Ending March 31, 2027, Payable on 11 November 2026 CI
07-14 Southern Acids (M) Berhad Reports Group Production Results for the Month of June 2026 CI
06-17 Southern Acids (M) Berhad Reports Group Production Results for the Month of May 2026 CI
05-22 Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended 31 March 2026 CI
05-22 Southern Acids (M) Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-22 Southern Acids (M) says Cheong Kee Yoong to retire as CFO RE
1 day+1.29%
1 week+1.62%
Current month+1.62%
1 month+3.63%
3 months+1.29%
6 months+3.63%
Current year-1.26%
1 week 3.06
Extreme 3.06
3.15
1 month 3
Extreme 3
3.15
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 46 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 46 28/08/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%+1.62%-7.65%-8.19% 106M
-1.97%+0.94%-5.97%+373.68% 5.31B
+0.62%+0.88%+42.55%+122.71% 1.91B
+2.52%+0.97%-1.06%+86.28% 850M
+3.10%+1.36%+50.82%+34.68% 668M
-1.24%+1.99%+36.90%+137.87% 620M
+3.84%+3.84%-5.33%-10.41% 542M
+4.46%+0.70%+82.33%+32.10% 469M
+0.43%-4.18%+9.27%+12.63% 422M
+0.86%+0.51%+8.97%+29.31% 302M
Average +1.39%-1.45%+21.08%+81.07% 1.12B
Weighted average by Cap. -0.10%-1.06%+13.13%+216.41%

Financials

2025 2026
Net sales 1.11B 273M 235M 221M 202M 377M 25.85B 379M 2.62B 1.01B 13.24B 1.03B 1B 42.17B 934M 231M 198M 187M 170M 319M 21.82B 320M 2.21B 855M 11.17B 867M 848M 35.6B
Net income 36.7M 9.07M 7.8M 7.34M 6.7M 12.53M 858M 12.57M 87M 33.63M 439M 34.07M 33.32M 1.4B 37.38M 9.24M 7.94M 7.47M 6.82M 12.76M 874M 12.8M 88.6M 34.25M 447M 34.69M 33.93M 1.43B
Net Debt -367M -90.68M -77.98M -73.34M -66.95M -125M -8.58B -126M -870M -336M -4.39B -341M -333M -13.99B -426M -105M -90.65M -85.26M -77.83M -146M -9.97B -146M -1.01B -391M -5.1B -396M -387M -16.26B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
07/09/26 MYR 3.140 +1.29% 16,700
03/09/26 MYR 3.100 +0.32% 3,000
  1. Stock Market
  2. Stocks
  3. 5134 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!